Its a collaborative trial Mangoman. I am sure J&J wrote some conditions of exclustivity into the contract, but exactly what we will never know. But its a collaboration so J&J must have some exclusitivity. I think its been forgotten over the years (these trials do take years at the best of time, then throw in COVID) that this is a collaborative trial with J&J as involved as OCC - just with domestic surgeons running the practicalities.
"Regenerative medicine company Orthocell Limited has today announced a research collaboration agreement with DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, for its Ortho-ATI® stem cell approach for the regeneration of degenerate tendons and ligaments. The collaboration was facilitated by Johnson & Johnson Innovation." (2017)
We should get the final data next week. I wouldn't expect a partnership to be announced with it, but that will hopefully follow. We know the stock consistently spikes on trial announcements of course.
- Forums
- ASX - By Stock
- OCC
- OCC Trading
OCC Trading, page-1019
-
- There are more pages in this discussion • 717 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
-0.005(1.35%) |
Mkt cap ! $76.49M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 36.5¢ | $33.04K | 89.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 54459 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 14827 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 54459 | 0.365 |
9 | 236523 | 0.360 |
3 | 39452 | 0.355 |
5 | 73573 | 0.350 |
2 | 38988 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 14827 | 1 |
0.375 | 1191 | 1 |
0.380 | 39868 | 3 |
0.390 | 25792 | 5 |
0.395 | 4908 | 1 |
Last trade - 15.46pm 14/08/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |